#FH20 Frontiers Health 2020: Home to Health Innovation Ecosystem

12 - 13 November 2020 Berlin, Germany.
In 2020 Frontiers Health conference will go in line with the rules of the "new normal": the event has a hybrid format - both offline and online - providing a variety of options to join the gathering of key innovators from the global healthcare industry.

During the last 5 years, Frontiers Health has turned into the unique platform for deal making, networking and learning in the digital health ecosystem. In 2019 the event taking place in Berlin had such a global reach that our attendees, 600+ industry experts from 30 countries, defined Frontiers Health the "home to the digital health ecosystem".

On the 12 - 13th November, 2020 FH Global Hybrid Conference will combine online and offline events and activities in Italy, Germany, Finland, Spain, the USA and more locations. Such format will give flexibility to attend Frontiers Health from any world’s location and get access to the top digital health community. The conference will be dedicated to all aspects of digital health innovation including digital therapies, breakthrough technologies, patient-centricity, healthcare transformation and so on.

The hybrid format will work in such a way that the offline attendees will be able to join plenary sessions in the local hubs together with the breakout sessions with the online community. It means that offline visitors will enjoy a "silent conference" experience. In addition, our delegates' networking opportunities are multiplied, having them the chance to meet like-minded innovators both at their doorstep and in dedicated and reserved virtual rooms. The iconic segment of the conference, the Start-up Discovery, is also moved online opening more opportunities and more tracks for digital health startups.

We can capitalize on the successful experience of the "Fight the pandemic" live event, held on the 22nd May 2020, catalyzing more than 20k visitors. The virtual 7-hour conference was dedicated to the global ecosystem’s response to the Covid-19 challenge, investigating proven solutions for reshaping healthcare in the new normal.

All this being said... get your ticket now and stay in touch for further news and updates about Frontiers Health Global Hybrid Conference.

We are happy to share with our readers the exclusive code (20% off). The code is FH20EHN20 and this is the direct registration web link: https://2020.frontiers.health/page/1573287/register?promo=FH20EHN20

Most Popular Now

The Future of Medicine is Data

At the 2023 Annual J.P. Morgan Healthcare Conference, Owkin Co-founder and CEO Thomas Clozel, MD will outline how data is the future of medicine - from the development of new...

Study Surveys Landscape of Apps Built on…

A study led by Regenstrief Institute Research Scientist Titus K. Schleyer, DMD, PhD, is among the first to survey the current landscape of FHIR® apps, providing a snapshot of how...

New Computer Program 'Learns' to Identif…

Genetic mutations cause hundreds of unsolved and untreatable disorders. Among them, DNA mutations in a small percentage of cells, called mosaic mutations, are extremely difficult to detect because they exist...

Applications Open for SpinLab Accelerato…

The start-up accelerator supports entrepreneurial and innovative teams that want to grow sustainably and successfully scale their business model. With a strong hands-on mentality and a lot of passion, the...

Bayer to Accelerate Drug Discovery with …

Bayer AG and Google Cloud today announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-developed accelerators designed to run...

Allscripts Announces Corporate Name Chan…

Allscripts Healthcare Solutions, Inc. announced that, effective January 1, 2023, it has changed its name to Veradigm Inc. (NASDAQ: MDRX). Allscripts had been transitioning its solutions to the Veradigm brand...

220M€ Investment in Testing and Experime…

To make the EU the place where AI excellence thrives from the lab to the market, the European Union is setting up world-class Testing and Experimentation Facilities (TEFs) for AI. Together...

AI Tool Developed to Predict Risk of Lun…

Lung cancer is the leading cause of cancer death in the United States and around the world. Low-dose chest computed tomography (LDCT) is recommended to screen people between 50 and...

Artificial Nerve Cells - Almost Like Bio…

Researchers at Linköping University (LiU), Sweden, have created an artificial organic neuron that closely mimics the characteristics of biological nerve cells. This artificial neuron can stimulate natural nerves, making it...

Bayer Acquires Blackford Analysis Ltd. B…

Bayer announced the acquisition of the global strategic imaging AI platform and solutions provider Blackford Analysis Ltd. The acquisition is part of Bayer's strategy to drive innovation in radiology, including...

For Shared Decision-Making, Telemedicine…

Telemedicine may be just as effective as in-person visits when it comes to shared decision-making and communication for patients undergoing a first-time surgery consultation, according to a study published as...

Veradigm Announces Strategic Investment …

Veradigm Inc. (NASDAQ: MDRX), formerly Allscripts Healthcare Solutions, Inc., announced an investment in Holmusk, a global behavioral health real-world evidence and data analytics company, as part of Holmusk's $45 million...